hepatocellular - Robuta Search

https://scholars.lib.ntu.edu.tw/entities/project/bd5d6094-576b-4141-99bb-ff8a30cbdddc The Pathophysiological Mechanism of Ischemia/Reperfusion Induced Hepatocellular Apoptosis mechanism ischemia reperfusion induced hepatocellular https://pmc.ncbi.nlm.nih.gov/articles/PMC6238087/ Update in global trends and aetiology of hepatocellular carcinoma - PMC Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver responsible for an increasing number of cancer-related deaths, especially in... global trends hepatocellular carcinoma update aetiology pmc https://publikationen.uni-tuebingen.de/xmlui/handle/10900/112021 Hybrid Modelling of Transarterial Chemoembolisation Therapies (TACE) for Hepatocellular Carcinoma... hybrid modelling chemoembolisation therapies tace https://biblio.ugent.be/publication/8736016 Risk of hepatocellular carcinoma in hepatitis B and D virus co-infected patients : a systematic... https://repository.si.edu/items/a44077f2-cdd2-478f-8e5e-2e101a27167d HEPATOCELLULAR CARCINOMA IN CAPTIVE SLENDER TAILED MEERKATS (SURICATA SURICATTA): 5 CASES hepatocellular carcinoma suricata suricatta captive slender https://hspop.uw.edu/publication/preventing-hepatitis-b-in-people-in-close-contact-with-hepatocellular-carcinoma-patients/ Preventing hepatitis B in people in close contact with hepatocellular carcinoma patients. - Health... Oberle MW, Shapiro CN, Lanier AP. Preventing hepatitis B in people in close contact with hepatocellular carcinoma patients. Public Health Rep. 1997... preventing hepatitis b close contact https://www.mdpi.com/2077-0383/10/2/221 Immunological Mechanisms for Hepatocellular Carcinoma Risk after Direct-Acting Antiviral Treatment... Direct-acting antiviral agents (DAAs) that allow for rapid clearance of hepatitis C virus (HCV) may evoke immunological changes. Some cases of rapid de novo... hepatocellular carcinoma direct acting immunological mechanisms https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1504917/full Frontiers | Efficacy and safety of neoadjuvant systemic therapy in resectable hepatocellular... BackgroundNeoadjuvant systemic therapy has been shown to benefit patients with solid tumors such as breast cancer and colorectal cancer, but its application ... efficacy and safety systemic therapy frontiers https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2024.1456455/full Frontiers | Sertraline induced acute hepatocellular liver injury in patient with major depressive... This case report describes a patient with major depressive disorder (MDD) who developed acute hepatocellular liver injury after being treated with sertraline... https://tagteam.harvard.edu/hub_feeds/3661/feed_items/11489606/controls TagTeam :: Bufalin suppresses hepatocellular carcinogenesis by targeting M2 macrophage-governed... tagteam hepatocellular carcinogenesis targeting macrophage https://pubmed.ncbi.nlm.nih.gov/41317730/ Molecular subtypes of hepatocellular carcinoma linked to liver cell lineages and clinical outcomes... Understanding the biology and clinical relevance of disease heterogeneity in hepatocellular carcinoma (HCC) is important for guiding therapeutic strategies.... https://dl.tufts.edu/concern/pdfs/3f462m45n PDF | Hepatocyte ploidy in cats with and without hepatocellular carcinoma. | ID: 3f462m45n | Tufts... https://pubmed.ncbi.nlm.nih.gov/28706416/ Implication of the Hedgehog pathway in hepatocellular carcinoma The prognosis for patients who are diagnosed with advanced stage hepatocellular carcinoma (HCC) is poor because there are few treatment options. Recent... of the implication hedgehog pathway hepatocellular https://cordis.europa.eu/project/id/667273/factsheet Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co-morbidities. | HEP-CAR... Hepatocellular carcinoma (HCC) is the most common liver malignancy, with an estimated 750,000 new cases and 695,000 deaths per year, rating third in incidence... hepatocellular carcinoma https://pure.psu.edu/en/publications/rhamnus-cathartica-buckthorn-hepatocellular-toxicity-in-mice/ Rhamnus cathartica (Buckthorn) hepatocellular toxicity in mice* - Penn State rhamnus cathartica buckthorn hepatocellular toxicity mice https://cordis.europa.eu/project/id/753534 Spatiotemporal dynamics of CD8+ T cell responses to hepatocellular carcinoma | Hepatocarcinoma IVM... CD8+ T cells have a key role in eliminating tumors that affect the liver. The protective capacity of these cells relies on their ability to migrate to the... t cell https://researchdiscovery.drexel.edu/esploro/outputs/doctoral/Elucidating-the-effects-of-interstitial-fluid/991014632571804721 Elucidating the effects of interstitial fluid flow on hepatocellular carcinoma invasion - Drexel... Over the last two decades with advancements in research, detection, and treatment of all cancer types in the United States, resulting in an overall 23%... fluid flow https://www.techtransfer.nih.gov/patent/e-215-2007-0-au-12 Methods for Determining Hepatocellular Carcinoma Subtype and Detecting Hepatic Cancer Stem Cells |... hepatocellular carcinoma https://www.wikidata.org/wiki/Q78991237 A transplantable bile-secreting hepatocellular carcinoma in the rat - Wikidata scientific article published on 01 April 1961 hepatocellular carcinoma the rat bile secreting wikidata https://publikationen.uni-tuebingen.de/xmlui/handle/10900/98080 Haprolid inhibits tumor growth of hepatocellular carcinoma through Rb/E2F and Akt/mTOR inhibition https://pubmed.ncbi.nlm.nih.gov/19665249/ Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib... Ras activation results from several molecular alterations, such as methylation of tumor suppressors and amplification of oncogenes (B-raf). Sorafenib blocks... https://pubmed.ncbi.nlm.nih.gov/41738362/ Optimizing Liver Transplant Allocation for Hepatocellular Carcinoma: Development and Validation of... The HCC-LTSB model accurately predicted the survival benefit provided by LT in candidates listed with unresectable HCC within UNOS criteria. liver transplant hepatocellular carcinoma optimizing allocation https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1487353/full Frontiers | Comparison of adjuvant treatment regimens for high-risk hepatocellular carcinoma: a... BackgroundThe five-year recurrence rate for patients with hepatocellular carcinoma (HCC) is as high as 70%. Patients with high-risk recurrence factors experi... https://www.frontiersin.org/journals/surgery/articles/10.3389/fsurg.2021.764887/full Frontiers | Enhanced Recovery After Surgery in Patients With Hepatocellular Carcinoma Undergoing... Objective: To compare the effectiveness and safety of enhanced recovery aftersurgery (ERAS) in patients with hepatocellular carcinoma (HCC) undergoinglaparos... recovery after surgery in patients hepatocellular carcinoma frontiers enhanced https://pubmed.ncbi.nlm.nih.gov/30310534/ Micro-RNAs in hepatitis B virus-related chronic liver diseases and hepatocellular carcinoma MicroRNAs (miRNAs) are small non-coding RNAs that modulate gene expression at the post-transcriptional level by affecting both the stability and translation of... hepatitis b virus https://www.techtransfer.nih.gov/patent/e-139-2012-2-us-13 (R,R')-4'-methoxy-1-naphthylfenoterol (MNF) For The Treatment Of Glioblastomas And Hepatocellular... https://publikationen.uni-tuebingen.de/xmlui/handle/10900/64918 Dysregulated Serum Response Factor Triggers Formation of Hepatocellular Carcinoma serum response factor triggers formation https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1214423/full Frontiers | Low host immune pressure may be associated with the development of hepatocellular... Background: It has been reported that hepatitis B virus (HBV) double mutations (A1762T, G1764A) are an aetiological factor of hepatocellular carcinoma (HCC).... https://pubmed.ncbi.nlm.nih.gov/25173978/ EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation Hepatocellular carcinoma (HCC) is a frequent cancer with limited treatment options and poor prognosis. Tumorigenesis has been linked with macrophage-mediated... https://www.news-medical.net/news/20260417/AGA-update-calls-for-better-surveillance-of-hepatocellular-carcinoma.aspx AGA update calls for better surveillance of hepatocellular carcinoma Apr 19, 2026 - A new update from the American Gastroenterological Association (AGA) urges stronger prevention efforts and better early-detection tools for hepatocellular... for better aga update calls surveillance https://researchconnect.buffalo.edu/en/publications/expression-of-src-and-fak-in-hepatocellular-carcinoma-and-the-eff/ Expression of Src and FAK in hepatocellular carcinoma and the effect of src inhibitors on... https://portal.research.lu.se/en/publications/unrecognized-liver-cirrhosis-is-common-and-associated-with-worse-/ Unrecognized liver cirrhosis is common and associated with worse survival in hepatocellular... liver cirrhosis https://www.techtransfer.nih.gov/patent/e-101-2016-0-cn-03 GENE SIGNATURE PREDICTIVE OF HEPATOCELLULAR CARCINOMA RESPONSE TO TRANSCATHETER ARTERIAL... hepatocellular carcinoma gene signature predictive response https://iris.cnr.it/handle/20.500.14243/485021 Extracellular Vesicle-Related Non-Coding RNAs in Hepatocellular Carcinoma: An Overview hepatocellular carcinoma extracellular vesicle related non https://pmc.ncbi.nlm.nih.gov/articles/PMC11424591/ Upregulation of EFCAB7 after radiofrequency ablation promoting hepatocellular carcinoma metastasis... Background: Radiofrequency ablation (RFA) is an established treatment for unresectable and early-stage hepatocellular carcinoma (HCC). However, in some cases,... radiofrequency ablation hepatocellular carcinoma promoting metastasis https://www.hsrd.research.va.gov/research/citations/PubBriefs/articles.cfm?RecordID=880 Direct-Acting Antiviral Agents Reduce Risk of Hepatocellular Cancer among Veterans with Hepatitis C... Oct 1, 2017 - HSR Publication Briefs https://pubmed.ncbi.nlm.nih.gov/36158319/ Effect of Lenvatinib treatment on the cell cycle and microRNA profile in hepatocellular carcinoma... Lenvatinib is a tyrosine kinase receptor inhibitor used to treat unresectable hepatocellular carcinoma (HCC). In this study, we investigated the antitumor... https://pubmed.ncbi.nlm.nih.gov/41327892/ Mitochondria-Targeted Nanomotor: H2S-Driven Cascade Therapy for Hepatocellular Carcinoma Despite advances in combination therapies for cancer treatment, most strategies rely on modular-additive designs that lack dynamic molecular cues to achieve... mitochondria targeted driven cascade therapy https://experts.colorado.edu/display/meshid_C04.557.470.200.025.255 Adenocarcinoma - Carcinoma, Hepatocellular | CU Experts | CU Boulder adenocarcinoma hepatocellular cu experts boulder https://refubium.fu-berlin.de/handle/fub188/13012 Refubium - 3D Quantitative tumour burden analysis in patients with hepatocellular carcinoma before... https://scholars.lib.ntu.edu.tw/entities/publication/2fe22d6b-d47f-42c5-9019-5c41ebecdeff Sorafenib Is Effective in Patients from the Asia-Pacific Region with Hepatocellular Carcinoma (Hcc)... the asia pacific region https://pubmed.ncbi.nlm.nih.gov/40385018/?dopt=Abstract Downregulated TRAF3IP2-AS1 promotes hepatocellular carcinoma progression through the... TRAF3IP2-AS1/miR-374a-5p/SEL1L/RPL6 pathway in HCC cells promoted DDR and HCC progression. Our data identify the role and mechanism of TRAF3IP2-AS1 in HCC and... hepatocellular carcinoma promotes progression https://ub01.uni-tuebingen.de/xmlui/handle/10900/65428?show=full Characterization of hepatocellular carcinoma (HCC) lesions using anovel CT-based volume perfusion... hepatocellular carcinoma https://www.research.va.gov/about/funded_research/proj-details-FY2022.cfm?pid=583746 I01BX004131-01 - DCLK1 is a Novel Molecular Target in Hepatocellular Carcinoma is a https://pubmed.ncbi.nlm.nih.gov/32379785/ The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib PNI represents a prognostic tool in advanced HCC treated with first-line Sorafenib. It is readily available and low-cost, and it could be implemented in... https://pubmed.ncbi.nlm.nih.gov/36111068/ Exposure to perfluoroalkyl substances and risk of hepatocellular carcinoma in a multiethnic cohort Per- and polyfluoroalkyl substances (PFAS), often referred to as "forever chemicals" because they are difficult to break down and stay in the human body for... https://research.birmingham.ac.uk/en/publications/the-polycomb-group-protein-bmi-1-is-a-novel-t-cell-antigen-in-hum/ The polycomb group protein BMI-1 is a novel T-cell antigen in human hepatocellular carcinoma -... https://cordis.europa.eu/project/id/661512/it A new tumor suppressor role for RSK2 in hepatocellular carcinoma | HepatoRiSK | Progetto | Scheda... Hepatocellular carcinoma (HCC) ranks third in cancer mortality worldwide. In spite of this, effective treatment options are limited, partly due to a poor... https://pubmed.ncbi.nlm.nih.gov/21992124/?dopt=Abstract Hepatocellular carcinoma Hepatocellular carcinoma hepatocellular carcinoma https://profiles.wustl.edu/en/publications/diagnostic-and-therapeutic-management-of-hepatocellular-carcinoma/fingerprints/ Diagnostic and therapeutic management of hepatocellular carcinoma - Fingerprint - WashU Research... hepatocellular carcinoma diagnostic therapeutic management fingerprint https://pubmed.ncbi.nlm.nih.gov/17216189/ KiSS-1 overexpression as an independent prognostic marker in hepatocellular carcinoma: an... The KiSS-1 gene has been reported to play an important role as a metastasis suppressor gene in various human malignancies. However, there is little information... kiss https://pubmed.ncbi.nlm.nih.gov/19910122/ Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma Hepatocellular carcinoma (HCC) is one of the most common cancers and lethal diseases in the world. Although the majority of HCC cases occur in developing... in the resveratrol chemoprevention treatment hepatocellular https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.954512/full Frontiers | Personalized quantitative models of NAD metabolism in hepatocellular carcinoma identify... Cancer cells are known to undergo metabolic adaptation to cater to their enhanced energy demand. Nicotinamide Adenine Dinucleotide (NAD) is an essential meta... quantitative models hepatocellular carcinoma frontiers personalized https://pubmed.ncbi.nlm.nih.gov/39852395/ Silymarin as a Therapeutic Agent for Hepatocellular Carcinoma: A Multi-Approach Computational Study This study provides a comprehensive in silico evaluation of silymarin's therapeutic potential in HCC. The findings suggest that silymarin, particularly its... as a https://www.techtransfer.nih.gov/patent/e-209-2008-0-es-10 USE OF MIR-26 FAMILY AS A PREDICTIVE MARKER OF HEPATOCELLULAR CARCINOMA AND RESPONSIVENESS TO... https://www.qk.sjtu.edu.cn/jscp/EN/abstract/article/1007-9610/44402 Current status and perspectives of conversion therapy for hepatocellular carcinoma current status conversion therapy perspectives hepatocellular carcinoma https://discovery.fiu.edu/display/pub197640 Serum microcystin levels positively linked with risk of hepatocellular carcinoma: A case-control... https://pubmed.ncbi.nlm.nih.gov/41714830/ ASO Visual Abstract: Cyclic GMP-AMP Synthase Expression in Hepatocellular Carcinoma: A Double-Edged... ASO Visual Abstract: Cyclic GMP-AMP Synthase Expression in Hepatocellular Carcinoma: A Double-Edged Biomarker for Prognosis and Immunotherapy Response https://news.med.miami.edu/tag/hepatocellular-carcinoma/ hepatocellular carcinoma Archives - InventUM hepatocellular carcinoma archives inventum https://scholars.lib.ntu.edu.tw/entities/project/2b88a5f7-3d4d-49fb-90c1-7ac4ea94d3ef Investigation on Therapeutic Role of Histone Deacetylase in Radiotherapy to Hepatocellular Carcinoma https://iris.cnr.it/handle/20.500.14243/420933 Galectin-1 and Its Involvement in Hepatocellular Carcinoma Aggressiveness hepatocellular carcinoma galectin involvement aggressiveness https://scholars.lib.ntu.edu.tw/entities/project/2f2f4ea8-700b-4ffb-9984-7b8fc52619ea Study on Searching for Putative Tumor Suppressor Genes in Human Hepatocellular Carcinoma searching for https://www.techtransfer.nih.gov/patent/e-215-2007-0-gb-22 Methods for determining a hepatocellular carcinoma subtype | Technology Transfer hepatocellular carcinoma methods determining subtype technology https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2020.628655/full Frontiers | Circular RNAs Sparkle in the Diagnosis and Theranostics of Hepatocellular Carcinoma AbstractExonic circular RNAs (circRNAs) are a novel subgroup of noncoding RNAs, which are generated by a back-splicing mechanism of the exons or introns. Unl... in the https://scholars.lib.ntu.edu.tw/entities/project/a6e8c91b-7e84-41f4-8af7-0fe2b40498d6 To Investigate the Roles of Epha2 and Yb-1 in Sorafenib Resistance and Metastasis of Hepatocellular... https://pubmed.ncbi.nlm.nih.gov/33197225/ Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Atezolizumab + bevacizumab (atezo + bev) may be offered as first-line treatment of most patients with advanced HCC, Child-Pugh class A liver disease, Eastern... systemic therapy for advanced hepatocellular carcinoma asco guideline https://pmc.ncbi.nlm.nih.gov/articles/PMC12119701/ Exosomes delivering miR-129-5p combined with sorafenib ameliorate hepatocellular carcinoma... Potassium channel tetramerization domain-containing 1 (KCTD1) plays a critical role in transcriptional regulation and adipogenesis, but its significance in... exosomes delivering mir https://research.monash.edu/en/publications/treatment-choice-for-early-stage-hepatocellular-carcinoma-in-real/ Treatment choice for early-stage hepatocellular carcinoma in real-world practice: impact of... https://pure.psu.edu/en/publications/aberrant-lipid-metabolism-in-hepatocellular-carcinoma-revealed-by/ Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid... lipid metabolism hepatocellular carcinoma aberrant https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.1009767/full Frontiers | Metabolomics profiling of AKT/c-Met-induced hepatocellular carcinogenesis and the... Hepatocellular carcinoma (HCC), the most common kind of liver cancer, accounts for the majority of liver cancer diagnoses and fatalities. Clinical aggressive... https://sysbiowiki.soe.ucsc.edu/node/553 Comprehensive and integrative genomic characterization of hepatocellular carcinoma | Systems... hepatocellular carcinoma comprehensive integrative genomic characterization https://repository.arizona.edu/handle/10150/633554?show=full Stereotactic body radiation therapy for hepatocellular carcinoma: Practice patterns, dose selection... radiation therapy hepatocellular carcinoma stereotactic body https://iob.ntu.edu.tw/zh_cn/Academic_Achievements/Journal_paper/Evaluation-of-predictive-value-of-CLIP-Okuda-TNM-and-JIS-staging-systems-for-hepatocellular-carcinoma-patients-undergoing-surgery-22185101 Evaluation of predictive value of CLIP Okuda TNM and JIS staging systems for hepatocellular... https://www.versitech.hku.hk/sc/technology/annexin-a3-as-a-diagnostic-biomarker-and-therapeutic-target-for-treating-hepatocellular-carcinoma Annexin A3 as a Diagnostic Biomarker and Therapeutic Target for Treating Hepatocellular Carcinoma -... https://www.qk.sjtu.edu.cn/jdcp/EN/abstract/article/1671-2870/48016 Current status, challenges and future directions for hepatocellular carcinoma surveillance in China current status future directions https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1110922/full Frontiers | Role of exosomes in hepatocellular carcinoma and the regulation of traditional Chinese... Hepatocellular carcinoma (HCC) usually occurs on the basis of chronic liver inflammatory diseases and cirrhosis. The liver microenvironment plays a vital rol... hepatocellular carcinoma https://publikationen.uni-tuebingen.de/xmlui/handle/10900/60440 TACE plus sorafenib for the treatment of hepatocellular carcinoma: results of the multicenter,... for the hepatocellular carcinoma tace plus sorafenib https://www.southampton.ac.uk/research/projects/yun-kimrip-hcc-risk-prediction-of-hepatocellular-carcinoma-using-machine-learning YUN KIMRIP-HCC | RIsk Prediction of HepatoCellular Carcinoma using machine learning in viral... YUN KIMRIP-HCC | RIsk Prediction of HepatoCellular Carcinoma using machine learning in viral hepatitis. https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.565266/full Frontiers | miR-631 Inhibits Intrahepatic Metastasis of Hepatocellular Carcinoma by Targeting PTPRE MicroRNAs (miRNAs) have been reported to play critical roles in the pathological development of hepatocellular carcinoma (HCC), one of the most common cancer... https://www.mdpi.com/2072-6694/15/6/1800 Integrated Analysis of N1-Methyladenosine Methylation Regulators-Related lncRNAs in Hepatocellular... N1-methyladenosine (m1A) and long non-coding RNAs (lncRNAs) play significant roles in tumor progression in hepatocellular carcinoma (HCC). However, their... integrated analysis https://pubmed.ncbi.nlm.nih.gov/40744051/ The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive... The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment the lancet hepatocellular carcinoma commission addressing global https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.1007382/full Frontiers | An update on the role of complement in hepatocellular carcinoma As a main producer of the complement, the environment in liver is greatly affected by complement system. Though the complement is considered as a nonself dis... an update on the frontiers https://pmc.ncbi.nlm.nih.gov/articles/PMC12309100/ NSUN5 accelerates the progression of liver hepatocellular carcinoma by m5C-EFNA3-mediated... Aerobic glycolysis is a hallmark of cancers including liver hepatocellular carcinoma (LIHC). RNA m5C methylation is involved in LIHC progression. However, the... the progression https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1253964/full Frontiers | Neutrophil extracellular traps regulating tumorimmunity in hepatocellular carcinoma As a component of the innate immune system, there is emerging evidence to suggest that neutrophils may play a critical role in the initiation and progression... frontiers neutrophil extracellular traps regulating https://pubmed.ncbi.nlm.nih.gov/35127513/ HCV Interplay With Mir34a: Implications in Hepatocellular Carcinoma Since its identification, HCV has been considered one of the main causes of hepatitis and liver cancer. Currently, the molecular mechanisms of HCC development... hcv interplay implications hepatocellular carcinoma https://pubmed.ncbi.nlm.nih.gov/31861402/ Overexpression of p62/IMP2 can Promote Cell Migration in Hepatocellular Carcinoma via Activation of... p62/IMP2 is an oncofetal protein that was first reported as a tumor-associated antigen in hepatocellular carcinoma (HCC). In our previous studies, we... https://researchdiscovery.drexel.edu/esploro/outputs/doctoral/Ultrasound-nano-scale-phase-change-contrast-agent/991021229715104721 Ultrasound nano-scale phase change contrast agent for hepatocellular carcinoma radiosensitization -... The purpose of this study was to develop and characterize nano-scale phase change droplets less than 200 nm from commercially available ultrasound contrast... phase change hepatocellular carcinoma ultrasound nano scale https://pubmed.ncbi.nlm.nih.gov/35116795/ Cisplatin chemotherapy-induced miRNA-210 signaling inhibits hepatocellular carcinoma cell growth Our findings defined a novel mechanism underlying the efficacious effects of cisplatin chemotherapy in HCC, and miR-210-induced EFNA3 signaling might be a... hepatocellular carcinoma cisplatin chemotherapy induced mirna https://pubmed.ncbi.nlm.nih.gov/30373752/ Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation... Linking NGS to routine clinical care has the potential to identify those patients with HCC likely to benefit from standard systemic therapies and can be used... hepatocellular carcinoma prospective genotyping clinical implications https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.985815/full Frontiers | Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms,... Hepatocellular carcinoma (HCC) is a complex and heterogeneous malignancy with high incidence and poor prognosis. In addition, owing to the lack of diagnostic... hepatocellular carcinoma frontiers non coding rnas https://our.utah.edu/ucur/identification-and-analysis-of-compounds-to-improve-ctnnb1-mutated-hepatocellular-carcinoma-hcc-in-transgenic-zebrafish/ Identification and Analysis of Compounds To Improve CTNNB1-mutated Hepatocellular Carcinoma (HCC)... https://pubmed.ncbi.nlm.nih.gov/30002715/ Regorafenib in hepatocellular carcinoma: latest evidence and clinical implications Over the past ten years, sorafenib, a multikinase inhibitor, has been the only systemic agent approved for first-line treatment of patients with unresectable... hepatocellular carcinoma regorafenib latest evidence clinical https://pubmed.ncbi.nlm.nih.gov/41383585/ Preoperative TACE with PD-1 inhibitors and TKIs in beyond "up-to-seven" hepatocellular carcinoma: a... Preoperative TACE with PD-1 inhibitors and TKIs was associated with improved survival without increasing severe complications in beyond "up-to-seven" HCC,... https://experts.umn.edu/en/publications/twisted-gastrulation-expression-in-cholangiocellular-and-hepatoce/ Twisted gastrulation expression in cholangiocellular and hepatocellular carcinoma -... twisted gastrulation expression hepatocellular carcinoma https://pubmed.ncbi.nlm.nih.gov/37522174/ Living Donor Liver Transplantation for Hepatocellular Carcinoma Within and Outside Traditional... Long-term survival is excellent for patients with HCC undergoing LDLT within and outside selection criteria, exceeding the minimum recommended 5-year rate of... living donor liver transplantation hepatocellular carcinoma https://pubmed.ncbi.nlm.nih.gov/39733089/ Yu-Ping-Feng-San improve the immunosuppression of microenvironment in hepatocellular carcinoma by... Yu-Ping-Feng-San (YPF) is a famous classical Chinese medicine formula known for its ability to boost immunity. YPF has been applied to enhance the immune... https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.574668/full Frontiers | Diffuse Recurrence of Hepatocellular Carcinoma After Liver Resection: Transarterial... This study aims to compare the effectiveness and complications of transarterial chemoembolization (TACE) combined with sorafenib (S-TACE) and TACE monotherap... hepatocellular carcinoma liver resection frontiers diffuse recurrence https://experts.umn.edu/en/publications/hepatitis-c-and-hepatocellular-carcinoma-in-latin-america-elimina/ Hepatitis C and hepatocellular carcinoma in Latin America: Elimination as a path to cancer... https://pubmed.ncbi.nlm.nih.gov/39927143/ Precision oncology through next generation sequencing in hepatocellular carcinoma Hepatocellular carcinoma (HCC) is a primary liver cancer that originates from underlying inflammation, often associated with Hepatitis B virus (HBV) or... next generation sequencing precision oncology hepatocellular carcinoma https://www.mdpi.com/1420-3049/27/21/7281 Prodigiosin from Serratia Marcescens in Cockroach Inhibits the Proliferation of Hepatocellular... Hepatocellular carcinoma (HCC) is the most common primary liver malignant tumor, and the targeted therapy for HCC is very limited. Our previous study... serratia